Investment Manager Monthly Commentary

April 2013

Regeneron Pharmaceuticals, Biogen Idec and Vertex Pharmaceuticals were up on positive news flow. Following several months of strong performance, Infinity’s stock retreated due in part to a large block sale from a prior collaborator, Purdue Pharma.
Read More…